Evidence map›Paper›PMID 38747519›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Choriocapillaris reduction accurately discriminates against early-onset Alzheimer's disease.

William Robert Kwapong, Fei Tang, Peng Liu, Ziyi Zhang, Le Cao, Zijuan Feng, Shiyun Yang, Yang Shu, Heng Xu, Ying Lu and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Distinct ocular microvascular alterations in Alzheimer's disease and cerebral small vessel disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Real-world prediction of early-onset dementia by health record data: A multi-center machine learning study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Review
  15. Glymphatic and meningeal lymphatic dysfunction in Alzheimer's disease: Mechanisms and therapeutic perspectives.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

William Robert KwapongDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Fei TangState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Peng LiuDepartment of Emergency, West China Hospital of Sichuan University, Chengdu, P.R. China.
Ziyi ZhangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Le CaoDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Zijuan FengDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Shiyun YangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Yang ShuState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Heng XuState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Ying LuState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Xinjun ZhaoState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Baochen ChongState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China.
Bo WuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Ming LiuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Peng LeiDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.
Shuting ZhangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, P.R. China.

Funding

Ministry of Science and Technology of the People's Republic of China 2021YFC2500100National Natural Science Foundation of China 82371210Science and Technology Department of Sichuan Province 2023YFS0266West China Hospital, Sichuan University 21HXFH042West China Hospital, Sichuan University ZYGD18009West China Hospital, Sichuan University ZYYC20009West China Hospital, Sichuan University ZYYC23016
6 · The paper itself

Abstract

introductionThis study addresses the urgent need for non-invasive early-onset Alzheimer's disease (EOAD) prediction. Using optical coherence tomography angiography (OCTA), we present a choriocapillaris model sensitive to EOAD, correlating with serum biomarkers.

methodsEighty-four EOAD patients and 73 controls were assigned to swept-source OCTA (SS-OCTA) or the spectral domain OCTA (SD-OCTA) cohorts. Our hypothesis on choriocapillaris predictive potential in EOAD was tested and validated in these two cohorts.

resultsBoth cohorts revealed diminished choriocapillaris signals, demonstrating the highest discriminatory capability (area under the receiver operating characteristic curve: SS-OCTA 0.913, SD-OCTA 0.991; P < 0.001). A sparser SS-OCTA choriocapillaris correlated with increased serum amyloid beta (Aβ)42, Aβ42/40, and phosphorylated tau (p-tau)181 levels (all P < 0.05). Apolipoprotein E status did not affect choriocapillaris measurement. DISCUSSION: The choriocapillaris, observed in both cohorts, proves sensitive to EOAD diagnosis, and correlates with serum Aβ and p-tau181 levels, suggesting its potential as a diagnostic tool for identifying and tracking microvascular changes in EOAD. HIGHLIGHTS: Optical coherence tomography angiography may be applied for non-invasive screening of Alzheimer's disease (AD). Choriocapillaris demonstrates high sensitivity and specificity for early-onset AD diagnosis. Microvascular dynamics abnormalities are associated with AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBiomarkersChoroidtau ProteinsTomography, Optical CoherenceAgedCohort StudiesFemaleHumansMaleMiddle AgedPeptide FragmentsAmyloid beta-PeptidesBiomarkersPeptide Fragmentstau Proteinsamyloid betachoriocapillarisearly‐onset dementiaretinal microvasculaturetau

Identifiers

PMID38747519
PMCPMC11180859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.